Ablation or conservative management of electrical storm due to monomorphic ventricular tachycardia: Differences in outcome

Europace

Volumn 14, Issue 12, 2012, Pages 1734-1739

  Izquierdo, Maite ^a   Ruiz Granell, Ricardo ^a   Ferrero, Angel ^a   Martínez, Angel ^a   Sánchez Gomez, Juanmiguel ^a   Bonanad, Clara ^a   Mascarell, Beatriz ^a   Morell, Salvador ^b   García Civera, Roberto ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Ablation; Electrical storm; Tachyarrhythmia

Indexed keywords

AMIODARONE; FLECAINIDE; MEXILETINE; PROCAINAMIDE; PROPAFENONE; SOTALOL;

ADULT; AGED; ARTICLE; CATHETER ABLATION; CONSERVATIVE TREATMENT; ELECTRICAL STORM; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART PACING; HEART VENTRICLE CONDUCTION; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SURVIVAL; TREATMENT OUTCOME;

AGED; ANTI-ARRHYTHMIA AGENTS; CATHETER ABLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 84870228561     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus186     Document Type: Article

References (12)

1. Exner D, Pinski S, Wyse G, Renfroe EG, Follmann D, Gold M et al. Electrical storm presages nonsudden death. The AVID trial. Circulation 2001;103:2066-71.
2. Sesselberg HW, Moss AJ, McNitt S, Zareba W, Daubert JP, Andrews ML et al. MADIT-II Research Group. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm 2007;4:1395-402. (Pubitemid 47578525)
3. Villacastin J, Almendral J, Arenal A, Albertos J, Ormaetxe J, Peinado R et al. Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillator. Circulation 1996; 93:753-62. (Pubitemid 26052462)
4. Ferreira-González I, Dos-Subirá L, Guyatt G.: Adjuntive antiarrhythmic drug therapy in patients with implantable cardioverter defibrillators: a systematic review. Eur Heart J 2007;28:469-77. (Pubitemid 47343564)
5. Carbucicchio C, Santamaría M, Trevisi N, Maccabelli G, Giraldi F, Fassini G et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short-and long-term outcomes in a prospective single-center study. Circulation 2008;117:462-9.
6. Kozeluhova M, Peichl P, Cihak R, Wichterle D, Vancura V, btesnik J et al. Catheter ablation of electrical storm in patients with structural heart disease. Europace 2011;13:109-13.
7. Deneke T, Shin DI, Lawo T, Bösche L, balta O, anders H et al. Catheter ablation of electrical storm in a collaborative hospital network. Am J Cardiol 2011;108:233-9.
8. Koźluk E, Gaj S, Kiliszek M, Lodziński P, Pia̧tkowska A, Opolski G.: Efficacy of catheter ablation in patients with an electrical storm. Kardiol Pol 2011;69:665-70.
9. Tung R, Josephson ME, Reddy V, Reynolds MR, SMASH-VT Investigators. Influence of clinical and procedural predictors on ventricular tachycardia ablation outcomes: an analysis from the substrate mapping and ablation in Sinus Rhythm to Halt Ventricular Tachycardia Trial (SMASH-VT). J Cardiovasc Electrophysiol 2010; 21:799-803.
10. Kosmidou I, Inada K, Seiler J, Koplan B, Stevenson WG, Tedrow UB. Role of repeat procedures for catheter ablation of postinfarction ventricular tachycardia. Heart Rhythm 2011;8:1516-22.
11. Arya A, Haghjoo M, Reza Dehghani M, Fazelifar A, Nikoo M, Bagherzadeh A et al. Prevalence and predictors of electrical storm in patients with implantable cardioverter-defibrillator. Am J Cardiol 2006;97:389-92. (Pubitemid 43133056)
12. Brigadeau F, Kouakam C, Klug D, Marquié C, Duhamel A, Mizon-Gérard F et al. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators. Eur Heart J 2006;27:700-7.